FRI0041 Pro-inflammatory cytokines IL-1[beta] and tnf-[alpha] regulate the genomic 5-hydroxymethylcytosine levels by modulating the expression and activity of tet-1 and idhs in human oa chondrocytes

Background 5-hydroxymethyl cytosine (5-hmC) was recently discovered as a new epigenetic mark widely distributed in all types of tissues with varying degrees of abundance. 5-hmC is formed by the oxidation of 5-mC by ten-eleven translocation (TET) family of enzymes (TET1, TET2 and TET3), which need α-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2013-06, Vol.72, p.A381
Hauptverfasser: Haseeb, A, Haqqi, T M
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page A381
container_title Annals of the rheumatic diseases
container_volume 72
creator Haseeb, A
Haqqi, T M
description Background 5-hydroxymethyl cytosine (5-hmC) was recently discovered as a new epigenetic mark widely distributed in all types of tissues with varying degrees of abundance. 5-hmC is formed by the oxidation of 5-mC by ten-eleven translocation (TET) family of enzymes (TET1, TET2 and TET3), which need α-ketoglutarate as a co-factor produced by isocitratedehydrogenases (IDHs). 5-hmC plays an important role in the regulation of gene expression by acting as an intermediate state of complete demethylation as well as by modulating the binding of transcription regulatory proteins. Pro-inflammatory cytokines IL-1β and TNF-α have been shown to modulate the expression of many genes in chondrocytes, resulting in the activation of catabolic mechanisms in the joint and ultimately causing the damage to articular cartilage. Objectives To determine (a) whether pro-inflammatory cytokines IL-1β and TNF-α regulate gene expression in human chondrocytes via modulating the level of 5-hmC; (b) the global occurrence of 5-hmC in primary human chondrocytes; and (c) whether pro-inflammatory cytokines modulate the expression and activity of TET and IDH enzymes and genomic DNA hydroxymethylation in human chondrocytes. Methods Primary human chondrocytes were isolated from the deep zone of the cartilage obtained from OA patients who underwent total joint replacement (n=8). Global 5-hmC content in the genomic DNA was quantified using a 5-hmC-specific ELISA (Epigentek, Farmingdale, NY). Total TET activity was determined by an ELISA based activity assay kit (Epigentek). Total IDH activity was determined by a colorimetric assay kit (Sigma Aldrich, St Louis, MO). Gene expression of MMP-3, TET-1, TET-2, TET-3, IDH-1 and IDH-2 was quantitated using the TaqMan assays (Applied Biosystems, Carlsbad, CA). Involvement of NF-kB in gene-regulation of TET-1 was investigated by using a small molecule inhibitor BAY 11-7082. Data were derived using Origin 6.1 software and P
doi_str_mv 10.1136/annrheumdis-2013-eular.1169
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1777913196</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008722041</sourcerecordid><originalsourceid>FETCH-proquest_journals_17779131963</originalsourceid><addsrcrecordid>eNqNjc1KAzEUhYMoWH_e4ULX0cSp87MWiwUXIu6KlHTmTpOanzHJlOYFfS7TwQdwdTnn3PMdQuac3XFelPfCWi9xNJ0K9IHxguKohc9Z2ZyRGV-UdbZLdk5mjLGCLpqyuiRXIeyzZDWvZ-Rn-b5ibMHhzTuqbK-FMSI6n6BN0X0piwFWr5SvtxjFJwjbQbQ9XQs9yKw97vJiRIgSYYfWGdXCI5Wp8-6YDEaZ9AkUMgg0HlAH2CYwrjvVlN1NRTwOHkNQzk4Doo3qoGIC10PESPnkqk4GUBbkaIQFJ6CVzuaZjMdwQy56oQPe_t1rMl8-fzy90MG77xFD3Ozd6G2ONryqqoYXvCmL_339AsV3dfo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777913196</pqid></control><display><type>article</type><title>FRI0041 Pro-inflammatory cytokines IL-1[beta] and tnf-[alpha] regulate the genomic 5-hydroxymethylcytosine levels by modulating the expression and activity of tet-1 and idhs in human oa chondrocytes</title><source>BMJ Journals Online Archive</source><creator>Haseeb, A ; Haqqi, T M</creator><creatorcontrib>Haseeb, A ; Haqqi, T M</creatorcontrib><description>Background 5-hydroxymethyl cytosine (5-hmC) was recently discovered as a new epigenetic mark widely distributed in all types of tissues with varying degrees of abundance. 5-hmC is formed by the oxidation of 5-mC by ten-eleven translocation (TET) family of enzymes (TET1, TET2 and TET3), which need α-ketoglutarate as a co-factor produced by isocitratedehydrogenases (IDHs). 5-hmC plays an important role in the regulation of gene expression by acting as an intermediate state of complete demethylation as well as by modulating the binding of transcription regulatory proteins. Pro-inflammatory cytokines IL-1β and TNF-α have been shown to modulate the expression of many genes in chondrocytes, resulting in the activation of catabolic mechanisms in the joint and ultimately causing the damage to articular cartilage. Objectives To determine (a) whether pro-inflammatory cytokines IL-1β and TNF-α regulate gene expression in human chondrocytes via modulating the level of 5-hmC; (b) the global occurrence of 5-hmC in primary human chondrocytes; and (c) whether pro-inflammatory cytokines modulate the expression and activity of TET and IDH enzymes and genomic DNA hydroxymethylation in human chondrocytes. Methods Primary human chondrocytes were isolated from the deep zone of the cartilage obtained from OA patients who underwent total joint replacement (n=8). Global 5-hmC content in the genomic DNA was quantified using a 5-hmC-specific ELISA (Epigentek, Farmingdale, NY). Total TET activity was determined by an ELISA based activity assay kit (Epigentek). Total IDH activity was determined by a colorimetric assay kit (Sigma Aldrich, St Louis, MO). Gene expression of MMP-3, TET-1, TET-2, TET-3, IDH-1 and IDH-2 was quantitated using the TaqMan assays (Applied Biosystems, Carlsbad, CA). Involvement of NF-kB in gene-regulation of TET-1 was investigated by using a small molecule inhibitor BAY 11-7082. Data were derived using Origin 6.1 software and P &lt;0.05 was considered significant. Results The global 5-hmC content in human chondrocytes was found to be 0.1-0.2% of the total genomic DNA. There was approximately 70% decrease (P&lt;0.05) in the 5-hmC content upon treatment with IL-1b plus TNFa for 48 hrs. This correlated with the reduction of total TET enzyme activity after treatment with IL-1b alone or with IL-1b + TNF-a. There was a 20 fold reduction in the level of TET-1 mRNA expression while there was a 2-3 fold increase in the expression of TET-3 mRNA. The level of TET-2 mRNA expression did not change upon treatment with the cytokines. Down-regulation of TET-1 gene expression by cytokines was NF-kB dependent. Treatment of human chondrocytes with IL-1b and TNF-a also resulted in down-regulation of IDH-1 and IDH-2 mRNA expression and decrease in total IDH enzymatic activity. Conclusions Our data demonstrate for the first time the presence of a significant amount of 5-hmC in human chondrocyte DNA. We also for the first time show that pro-inflammatory cytokines IL-1β and TNF-α modulate the 5-hmC content in the genomic DNA via modulating the gene expression and activities of TET and IDH enzymes. Taken together our novel data (a) suggests that inflammatory cytokines-induced hydroxymethylation of genomic DNA in OA chondrocytes may be involved in active demethylation of target promoters; and (b) these data identify novel targets for the development of OA therapeutics. Acknowledgements Supported by AT 003627 and AT 005520 from NIH. Disclosure of Interest A. Haseeb: None Declared, T. Haqqi Grant/research support from: NIH</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2013-eular.1169</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><ispartof>Annals of the rheumatic diseases, 2013-06, Vol.72, p.A381</ispartof><rights>Copyright: 2013 (c) 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Haseeb, A</creatorcontrib><creatorcontrib>Haqqi, T M</creatorcontrib><title>FRI0041 Pro-inflammatory cytokines IL-1[beta] and tnf-[alpha] regulate the genomic 5-hydroxymethylcytosine levels by modulating the expression and activity of tet-1 and idhs in human oa chondrocytes</title><title>Annals of the rheumatic diseases</title><description>Background 5-hydroxymethyl cytosine (5-hmC) was recently discovered as a new epigenetic mark widely distributed in all types of tissues with varying degrees of abundance. 5-hmC is formed by the oxidation of 5-mC by ten-eleven translocation (TET) family of enzymes (TET1, TET2 and TET3), which need α-ketoglutarate as a co-factor produced by isocitratedehydrogenases (IDHs). 5-hmC plays an important role in the regulation of gene expression by acting as an intermediate state of complete demethylation as well as by modulating the binding of transcription regulatory proteins. Pro-inflammatory cytokines IL-1β and TNF-α have been shown to modulate the expression of many genes in chondrocytes, resulting in the activation of catabolic mechanisms in the joint and ultimately causing the damage to articular cartilage. Objectives To determine (a) whether pro-inflammatory cytokines IL-1β and TNF-α regulate gene expression in human chondrocytes via modulating the level of 5-hmC; (b) the global occurrence of 5-hmC in primary human chondrocytes; and (c) whether pro-inflammatory cytokines modulate the expression and activity of TET and IDH enzymes and genomic DNA hydroxymethylation in human chondrocytes. Methods Primary human chondrocytes were isolated from the deep zone of the cartilage obtained from OA patients who underwent total joint replacement (n=8). Global 5-hmC content in the genomic DNA was quantified using a 5-hmC-specific ELISA (Epigentek, Farmingdale, NY). Total TET activity was determined by an ELISA based activity assay kit (Epigentek). Total IDH activity was determined by a colorimetric assay kit (Sigma Aldrich, St Louis, MO). Gene expression of MMP-3, TET-1, TET-2, TET-3, IDH-1 and IDH-2 was quantitated using the TaqMan assays (Applied Biosystems, Carlsbad, CA). Involvement of NF-kB in gene-regulation of TET-1 was investigated by using a small molecule inhibitor BAY 11-7082. Data were derived using Origin 6.1 software and P &lt;0.05 was considered significant. Results The global 5-hmC content in human chondrocytes was found to be 0.1-0.2% of the total genomic DNA. There was approximately 70% decrease (P&lt;0.05) in the 5-hmC content upon treatment with IL-1b plus TNFa for 48 hrs. This correlated with the reduction of total TET enzyme activity after treatment with IL-1b alone or with IL-1b + TNF-a. There was a 20 fold reduction in the level of TET-1 mRNA expression while there was a 2-3 fold increase in the expression of TET-3 mRNA. The level of TET-2 mRNA expression did not change upon treatment with the cytokines. Down-regulation of TET-1 gene expression by cytokines was NF-kB dependent. Treatment of human chondrocytes with IL-1b and TNF-a also resulted in down-regulation of IDH-1 and IDH-2 mRNA expression and decrease in total IDH enzymatic activity. Conclusions Our data demonstrate for the first time the presence of a significant amount of 5-hmC in human chondrocyte DNA. We also for the first time show that pro-inflammatory cytokines IL-1β and TNF-α modulate the 5-hmC content in the genomic DNA via modulating the gene expression and activities of TET and IDH enzymes. Taken together our novel data (a) suggests that inflammatory cytokines-induced hydroxymethylation of genomic DNA in OA chondrocytes may be involved in active demethylation of target promoters; and (b) these data identify novel targets for the development of OA therapeutics. Acknowledgements Supported by AT 003627 and AT 005520 from NIH. Disclosure of Interest A. Haseeb: None Declared, T. Haqqi Grant/research support from: NIH</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNjc1KAzEUhYMoWH_e4ULX0cSp87MWiwUXIu6KlHTmTpOanzHJlOYFfS7TwQdwdTnn3PMdQuac3XFelPfCWi9xNJ0K9IHxguKohc9Z2ZyRGV-UdbZLdk5mjLGCLpqyuiRXIeyzZDWvZ-Rn-b5ibMHhzTuqbK-FMSI6n6BN0X0piwFWr5SvtxjFJwjbQbQ9XQs9yKw97vJiRIgSYYfWGdXCI5Wp8-6YDEaZ9AkUMgg0HlAH2CYwrjvVlN1NRTwOHkNQzk4Doo3qoGIC10PESPnkqk4GUBbkaIQFJ6CVzuaZjMdwQy56oQPe_t1rMl8-fzy90MG77xFD3Ozd6G2ONryqqoYXvCmL_339AsV3dfo</recordid><startdate>20130601</startdate><enddate>20130601</enddate><creator>Haseeb, A</creator><creator>Haqqi, T M</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20130601</creationdate><title>FRI0041 Pro-inflammatory cytokines IL-1[beta] and tnf-[alpha] regulate the genomic 5-hydroxymethylcytosine levels by modulating the expression and activity of tet-1 and idhs in human oa chondrocytes</title><author>Haseeb, A ; Haqqi, T M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_17779131963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haseeb, A</creatorcontrib><creatorcontrib>Haqqi, T M</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haseeb, A</au><au>Haqqi, T M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FRI0041 Pro-inflammatory cytokines IL-1[beta] and tnf-[alpha] regulate the genomic 5-hydroxymethylcytosine levels by modulating the expression and activity of tet-1 and idhs in human oa chondrocytes</atitle><jtitle>Annals of the rheumatic diseases</jtitle><date>2013-06-01</date><risdate>2013</risdate><volume>72</volume><spage>A381</spage><pages>A381-</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Background 5-hydroxymethyl cytosine (5-hmC) was recently discovered as a new epigenetic mark widely distributed in all types of tissues with varying degrees of abundance. 5-hmC is formed by the oxidation of 5-mC by ten-eleven translocation (TET) family of enzymes (TET1, TET2 and TET3), which need α-ketoglutarate as a co-factor produced by isocitratedehydrogenases (IDHs). 5-hmC plays an important role in the regulation of gene expression by acting as an intermediate state of complete demethylation as well as by modulating the binding of transcription regulatory proteins. Pro-inflammatory cytokines IL-1β and TNF-α have been shown to modulate the expression of many genes in chondrocytes, resulting in the activation of catabolic mechanisms in the joint and ultimately causing the damage to articular cartilage. Objectives To determine (a) whether pro-inflammatory cytokines IL-1β and TNF-α regulate gene expression in human chondrocytes via modulating the level of 5-hmC; (b) the global occurrence of 5-hmC in primary human chondrocytes; and (c) whether pro-inflammatory cytokines modulate the expression and activity of TET and IDH enzymes and genomic DNA hydroxymethylation in human chondrocytes. Methods Primary human chondrocytes were isolated from the deep zone of the cartilage obtained from OA patients who underwent total joint replacement (n=8). Global 5-hmC content in the genomic DNA was quantified using a 5-hmC-specific ELISA (Epigentek, Farmingdale, NY). Total TET activity was determined by an ELISA based activity assay kit (Epigentek). Total IDH activity was determined by a colorimetric assay kit (Sigma Aldrich, St Louis, MO). Gene expression of MMP-3, TET-1, TET-2, TET-3, IDH-1 and IDH-2 was quantitated using the TaqMan assays (Applied Biosystems, Carlsbad, CA). Involvement of NF-kB in gene-regulation of TET-1 was investigated by using a small molecule inhibitor BAY 11-7082. Data were derived using Origin 6.1 software and P &lt;0.05 was considered significant. Results The global 5-hmC content in human chondrocytes was found to be 0.1-0.2% of the total genomic DNA. There was approximately 70% decrease (P&lt;0.05) in the 5-hmC content upon treatment with IL-1b plus TNFa for 48 hrs. This correlated with the reduction of total TET enzyme activity after treatment with IL-1b alone or with IL-1b + TNF-a. There was a 20 fold reduction in the level of TET-1 mRNA expression while there was a 2-3 fold increase in the expression of TET-3 mRNA. The level of TET-2 mRNA expression did not change upon treatment with the cytokines. Down-regulation of TET-1 gene expression by cytokines was NF-kB dependent. Treatment of human chondrocytes with IL-1b and TNF-a also resulted in down-regulation of IDH-1 and IDH-2 mRNA expression and decrease in total IDH enzymatic activity. Conclusions Our data demonstrate for the first time the presence of a significant amount of 5-hmC in human chondrocyte DNA. We also for the first time show that pro-inflammatory cytokines IL-1β and TNF-α modulate the 5-hmC content in the genomic DNA via modulating the gene expression and activities of TET and IDH enzymes. Taken together our novel data (a) suggests that inflammatory cytokines-induced hydroxymethylation of genomic DNA in OA chondrocytes may be involved in active demethylation of target promoters; and (b) these data identify novel targets for the development of OA therapeutics. Acknowledgements Supported by AT 003627 and AT 005520 from NIH. Disclosure of Interest A. Haseeb: None Declared, T. Haqqi Grant/research support from: NIH</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/annrheumdis-2013-eular.1169</doi></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2013-06, Vol.72, p.A381
issn 0003-4967
1468-2060
language eng
recordid cdi_proquest_journals_1777913196
source BMJ Journals Online Archive
title FRI0041 Pro-inflammatory cytokines IL-1[beta] and tnf-[alpha] regulate the genomic 5-hydroxymethylcytosine levels by modulating the expression and activity of tet-1 and idhs in human oa chondrocytes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A45%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=FRI0041%20Pro-inflammatory%20cytokines%20IL-1%5Bbeta%5D%20and%20tnf-%5Balpha%5D%20regulate%20the%20genomic%205-hydroxymethylcytosine%20levels%20by%20modulating%20the%20expression%20and%20activity%20of%20tet-1%20and%20idhs%20in%20human%20oa%20chondrocytes&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Haseeb,%20A&rft.date=2013-06-01&rft.volume=72&rft.spage=A381&rft.pages=A381-&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2013-eular.1169&rft_dat=%3Cproquest%3E4008722041%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777913196&rft_id=info:pmid/&rfr_iscdi=true